Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Novello

Showing results (671-680 of 1,095) with videos related to

Pageof 110
Sort By:
ESMO Open|August 2, 2017
Time since start of first-line therapy as a predictive clinical marker for nintedanib in patients with previously treated non-small cell lung cancerBirgit Gaschler-Markefski, Patricia Sikken, John V Heymach, et al.
ESMO Open|December 18, 2018
Chemotherapy versus erlotinib as second-line treatment in patients with advanced non-small cell lung cancer and wild-type epidermal growth factor receptor: an individual patient data (IPD) analysisMarina Chiara Garassino, Tomoya Kawaguchi, Vanesa Gregorc, et al.
Lung Cancer (Amsterdam, Netherlands)|March 31, 2009
Randomised multicenter phase II study of two schedules of docetaxel and gemcitabine or cisplatin/gemcitabine followed by docetaxel as first line treatment for advanced non-small cell lung cancerSilvia Novello, Alfredo Falcone, Lucio Crinò, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|May 26, 2011
Phase II study of sunitinib in patients with non-small cell lung cancer and irradiated brain metastasesSilvia Novello, Carlos Camps, Francesco Grossi, et al.
Public Health Reports (Washington, D.C. : 1974)|March 1, 1990
HIV seroprevalence surveys of childbearing women--objectives, methods, and uses of the dataM Pappaioanou, J R George, W H Hannon, et al.
Psychiatry Research|September 15, 2018
The identification of biomarkers predicting acute and maintenance lithium treatment response in bipolar disorder: A plea for further research attentionMichele Fornaro, Domenico De Berardis, Annalisa Anastasia, et al.
Italian Journal of Pediatrics|December 30, 2025
The assessment of continuity of care and care coordination for Children and Youth with Special Health Care Needs (CYSHCN): a cross-sectional descriptive study in Northeastern ItalyElisa Zanello, Adele Maggiore, Raffaella Dobrina, et al.
JASA Express Letters|November 6, 2025
Stable adaptive training for physics-informed neural networks in acoustic wave propagationMárcio Marques, Leonardo Mendonça, Arthur Bizzi, et al.
Frontiers in Surgery|May 25, 2026
Poly-L-lactic acid (PLLA) in arm contouring: a prospective and blinded trial of Rennova® Elleva and Sculptra®Bruna Souza Felix Bravo, Ana Luisa Leopoldino de Souza, Emmanuela Beatriz Vantini Barreiro, et al.
Journal of Alzheimer'S Disease : JAD|February 15, 2012
Possible influence of a non-synonymous polymorphism located in the NGF precursor on susceptibility to late-onset Alzheimer's disease and mild cognitive impairmentEmilio Di Maria, Elisa Giorgio, Vera Uliana, et al.
Pageof 110

Showing results (671-680 of 1,095) with videos related to

Sort By:
Pageof 110
ESMO Open|August 2, 2017
Time since start of first-line therapy as a predictive clinical marker for nintedanib in patients with previously treated non-small cell lung cancerBirgit Gaschler-Markefski, Patricia Sikken, John V Heymach, et al.
ESMO Open|December 18, 2018
Chemotherapy versus erlotinib as second-line treatment in patients with advanced non-small cell lung cancer and wild-type epidermal growth factor receptor: an individual patient data (IPD) analysisMarina Chiara Garassino, Tomoya Kawaguchi, Vanesa Gregorc, et al.
Lung Cancer (Amsterdam, Netherlands)|March 31, 2009
Randomised multicenter phase II study of two schedules of docetaxel and gemcitabine or cisplatin/gemcitabine followed by docetaxel as first line treatment for advanced non-small cell lung cancerSilvia Novello, Alfredo Falcone, Lucio Crinò, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|May 26, 2011
Phase II study of sunitinib in patients with non-small cell lung cancer and irradiated brain metastasesSilvia Novello, Carlos Camps, Francesco Grossi, et al.
Public Health Reports (Washington, D.C. : 1974)|March 1, 1990
HIV seroprevalence surveys of childbearing women--objectives, methods, and uses of the dataM Pappaioanou, J R George, W H Hannon, et al.
Psychiatry Research|September 15, 2018
The identification of biomarkers predicting acute and maintenance lithium treatment response in bipolar disorder: A plea for further research attentionMichele Fornaro, Domenico De Berardis, Annalisa Anastasia, et al.
Italian Journal of Pediatrics|December 30, 2025
The assessment of continuity of care and care coordination for Children and Youth with Special Health Care Needs (CYSHCN): a cross-sectional descriptive study in Northeastern ItalyElisa Zanello, Adele Maggiore, Raffaella Dobrina, et al.
JASA Express Letters|November 6, 2025
Stable adaptive training for physics-informed neural networks in acoustic wave propagationMárcio Marques, Leonardo Mendonça, Arthur Bizzi, et al.
Frontiers in Surgery|May 25, 2026
Poly-L-lactic acid (PLLA) in arm contouring: a prospective and blinded trial of Rennova® Elleva and Sculptra®Bruna Souza Felix Bravo, Ana Luisa Leopoldino de Souza, Emmanuela Beatriz Vantini Barreiro, et al.
Journal of Alzheimer'S Disease : JAD|February 15, 2012
Possible influence of a non-synonymous polymorphism located in the NGF precursor on susceptibility to late-onset Alzheimer's disease and mild cognitive impairmentEmilio Di Maria, Elisa Giorgio, Vera Uliana, et al.
Pageof 110